Neustar Launches Next Generation DDoS Defense Network: SiteProtect NG™
Neustar, Inc., a trusted, neutral provider of real-time information services, today launched SiteProtect NG™ (Next Generation), its new solution to protect brands against DDoS (distributed denial of service) attacks.
It is the latest wave of the company’s purpose-built DDoS mitigation solution designed to meet the security requirements of all brands, on-premise and in the cloud, to deal with the next generation of cyber threats. This powerful upgrade adds Neustar’s state of the art WAF (web application firewall) solution to the award-winning Neustar SiteProtect solution to extend network protection to the application layer. A new real-time user interface provides consolidated in-depth trend analysis and gives brands unprecedented access to attack forensics that are not currently available through traditional defense services.
“Years of experience and cybersecurity engineering capabilities have gone into the development of the SiteProtect NG defense network and operating portal,” said Barrett Lyon, Vice President, Research and Development, Neustar Security Solutions. “Neustar is investing in the future of DDoS defense from an architectural standpoint and sees the expansion and closer integration of its security solutions portfolio as a long term strategic commitment for the company.”
“Neustar’s clients have the best protection, best user experience, broadest selection of configurations, and powerful analytics at their disposal. DDoS attacks will continue to present brands across the globe with significant challenges to their operational efficiency for the foreseeable future, and our investment in mitigation solutions will continue at pace,” added Lyon.
SiteProtect NG breaks with the tradition of designing network protection that makes use of a high volume of small scrubbing centers with fewer, highly fortified and highly connected locations. SiteProtect NG network has deployed large, full scale, nodes, each with its multi-terabit scrubbing capacity in North America, Europe, and Asia with South America, Africa, Australia, and India slated for early 2018.
“DDoS attacks reached unprecedented levels in 2017 and all trends Neustar is mapping indicate that 2018 is going to see the situation worsen dramatically. Cybercriminals, both private and state funded, have the wherewithal to surgically target individual brands, or initiate brute force attacks with the potential to cause catastrophic damage on a global scale. For many cybersecurity professionals, there is no respite, with attackers probing and often breaching defenses on a daily basis,” commented Rodney Joffe, Senior Vice President and Fellow, Neustar.
“Future proofing mitigation networks to stop attacks before they reach their target destination will save brands billions each year from the impact of DDoS attacks. Neustar’s R&D spend is reflective of the very real need to continually innovate in the face of such adversity and today protects thousands of brands from an increasingly diverse threat landscape. SiteProtect NG is a product that leverages the latest innovations in internet security and evolves to meet existing and future requirements.”
Neustar is giving clients more control and more functionality to build stronger defenses for their brands against DDoS attacks than ever before. The SiteProtect NG mitigation network combines innovative technologies and advancements from existing Neustar security solutions with powerful data traffic analytics powered by machine learning data analytics. This gives brands in-depth trend and attack analysis, leaving them with invaluable insights, which enable them to make smarter decisions about the configuration of their network security moving forward.
About Neustar Security Solutions
Neustar Security Solutions defend against network threats, inform you of potential network vulnerabilities, accelerate online asset performance, and monitor client website performance through multiple services and offerings. Neustar will offer the largest, most distributed DDoS mitigation network in the world with over 10 Tbps of capacity, and our industry leading SiteProtect DDoS defense service ensures full coverage in an attack. Our UltraDNS service manages 10% of all internet traffic, routes over 1 trillion queries a month and provides industry leading uptime with 100% availability. Our nearly 20 years of unparalleled expertise ensures that our customers are protected and optimized during normal business practices and when unsolicited events occur. Our services ensure customers network connectivity are protected and optimized whether in crisis or just business as usual. We are trusted by many of the world’s largest brands to keep their mission critical systems up and running.
More information is available at www.security.neustar
Neustar, Inc. is a leading global information services provider driving the connected world forward with trusted, holistic identity resolution. As the only company capable of understanding who is on the other end of every interaction, Neustar is trusted by the world’s great brands to grow and guard their businesses with the most complete knowledge of how to connect people, places and things. The combination of Neustar’s unique, accurate, and real-time identity system and our cloud-based workflow solutions empower our clients to make actionable, precise and valuable decisions across marketing, risk, IT/security, network & operations departments. As the sole provider of the U.S. Number Portability Administration Center, Neustar also facilitates the routing of all telephone call and text messages in the U.S. More information is available at https://www.home.neustar.
0207 608 8344
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 10:49 | Pressemelding
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha